Cargando…
Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study
BACKGROUND: To assess the efficacy and safety of recombinant human adenovirus type 5 (H101) in patients with persistent, recurrent, or metastatic gynecologic malignancies. METHODS: The study retrospectively enrolled patients with persistent/recurrent/metastatic gynecologic malignancies who received...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095970/ https://www.ncbi.nlm.nih.gov/pubmed/35574359 http://dx.doi.org/10.3389/fonc.2022.877155 |